特他洛爾
外觀
臨床資料 | |
---|---|
AHFS/Drugs.com | 國際藥品名稱 |
給藥途徑 | 口服 |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
識別資訊 | |
| |
CAS號 | 83688-84-0 |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.073.179 |
化學資訊 | |
化學式 | C16H25NO2S |
摩爾質量 | 295.44 g·mol−1 |
3D模型(JSmol) | |
手性 | 外消旋體 |
| |
|
特他洛爾(英語:Tertatolol),商品名Artex、Artexal、Prenalex,是一種β受體阻滯劑,用於治療高血壓。它是由法國施維雅製藥公司發現的,並在歐洲銷售。[1]
特他洛爾還被證明可作為血清素5-HT1A和5-HT1B受體拮抗劑,類似於普萘洛爾和吲哚洛爾。[2][3][4]
參見
[編輯]參考資料
[編輯]- ^ Swiss Pharmaceutical Society. Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. 2000. ISBN 3-88763-075-0.
- ^ Langlois M, Brémont B, Rousselle D, Gaudy F. Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors. European Journal of Pharmacology. January 1993, 244 (1): 77–87. PMID 8093601. doi:10.1016/0922-4106(93)90061-d.
- ^ Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, et al. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. May 1993, 347 (5): 453–463. PMID 7686633. S2CID 22129922. doi:10.1007/bf00166735.
- ^ van Wijngaarden I, Soudijn W, Tulp MT. 5-HT1A Receptors. Soudijn W, Olivier B, van Wijngaarden I (編). Serotonin Receptors and Their Ligands. Amsterdam: Elsevier. 1997. ISBN 0-444-82041-8.